Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial (2020)
Attributed to:
Oesophago-gastric adenocarcinoma: understanding disease pathogenesis and applications to earlier diagnosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 396
Parent Publication: LANCET
Issue: 10247
ISSN: 0140-6736